Friday, 26.04.2024, 10:52
Main Sign Up Login
Welcome, Guest · RSS
Site menu
Это важно!

Search
Calendar
«  April 2024  »
SuMoTuWeThFrSa
 123456
78910111213
14151617181920
21222324252627
282930
Statistics

Total online: 1
Guests: 1
Users: 0
 THE SALE OF KNOW-HOW

THE SALE OF KNOW-HOW

The multicomponent technology, the know-how, for the treatment of
extremely severe and incurable diseases is offered for sale. The short list of these diseases is: Epilepsy, Multiple Sclerosis, Cerebral Palsy, Autism, Diabetes, Cancer, Psoriasis, Vitiligo, Glaucoma, Joint diseases, Scleroderma and many other incurable diseases. One of the components of this technology is the bioresonance therapy. (See the article on the bio-resonance therapy). It is not the know-how. All other components of the know-how are sold.
This technology (the know-how) allows to treat diseases extremely effectively - much more effectively than the existing treatments. It is also as safe as the bioresonance therapy.
To the attention of the pharmaceutical companies: In the treatment method of the bioresonance therapy the medical information can be recorded on a) the water, b) the sugar semolina or other information carriers. The sold know-how also allows to record the medical information on the same carriers. The proposed know-how makes it possible to produce within the framework of the pharmaceutical companies the finished forms of similar drugs, to multiply them in unlimited quantities and sell them as ready-made medications. The know-how offered for sale allows to create finished medications that can be sold in pharmacy chains and used in medical institutions. They are significantly more efficient than the existing ones. Besides, the sold know-how allows to quickly improve the drugs and to create the new products based on the existing ones with the help of our know-how. The manufacture of new medications using our know-how takes a minimal amount of time (several hours or days), while many years are required for the manufacture of the products by means of the conventional technology. The cost of creating a new medication using our know-how is extremely small. It is measured in hundreds of dollars, while the creation of a new medication on the basis of the existing technologies costs many tens or hundreds of millions of dollars. Using our know-how, the drugmaker will be a monopolist during the time of the application of this drug.
There can be as many types of medications as the number of diseases treated by this technology.
V. Friedman was awarded the Golden Star of the Fatherland in Russia for his outstanding contribution to the treatment of very severe and incurable diseases through the know-how created and used by him.
Phone 050 99 00 739 in Israel
from other countries
8-10 - 972-50 99 00 739
Professor Victor Friedman

 

Copyright MyCorp © 2024